Screener
Organon OGN Other — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| ($ in millions) | Three Months Ended March 31, 2025 / U.S. | 2025 / Int’l | Total | U.S. | Int’l | Total |
|---|---|---|---|---|---|---|
| Nexplanon/Implanon NXT | $127 | $74 | $201 | $176 | $72 | $248 |
| Follistim AQ | 21 | 39 | 61 | 35 | 34 | 69 |
| NuvaRing | 6 | 18 | 24 | 6 | 16 | 22 |
| Ganirelix Acetate Injection | 2 | 24 | 26 | 5 | 23 | 27 |
| Marvelon/Mercilon | — | 26 | 26 | — | 39 | 39 |
| Jada | 5 | — | 5 | 15 | — | 15 |
| Other Women’s Health (1) | 17 | 30 | 46 | 15 | 27 | 43 |
| General Medicines |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's other — revenue?
- Organon (OGN) reported other — revenue of $23M in Q1 2026.
- How has Organon's other — revenue changed year-over-year?
- Organon's other — revenue decreased by 23.3% year-over-year, from $30M to $23M.
- What is the long-term trend for Organon's other — revenue?
- Over 4 years (2021 to 2025), Organon's other — revenue has grown at a -20.6% compound annual growth rate (CAGR), from $231M to $92M.
- What does other — revenue mean?
- This metric represents the total revenue generated from geographic regions outside of the company's primary reporting markets. It captures the performance of international sales in territories that do not meet the threshold for individual segment disclosure. Monitoring this metric helps investors assess the company's global footprint and the diversification of its revenue streams across emerging or smaller international markets.
Ask your AI about Organon's other — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude